|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.66 USD | +3.45% |
|
+10.87% | +8.43% |
| 07-18 | Avalo Therapeutics Says Some Shareholders May Sell Up to 128,189 Shares | MT |
| 07-05 | Certain Common Stock of Avalo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUL-2026. | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.45% | +10.87% | +6.55% | +46.94% | +8.43% | +195.65% | -58.98% | -99.74% | -99.81% | 1.01B | |
| -3.74% | -6.32% | -7.99% | +11.77% | +4.16% | +42.70% | +63.37% | +190.17% | +5,979.80% | 55.2B | |
| -0.81% | -0.33% | -0.55% | +12.86% | +38.44% | +27.15% | +81.12% | -19.55% | - | 55.6B | |
| -0.82% | +0.20% | -0.87% | -10.83% | -3.10% | -16.18% | -15.27% | -71.91% | - | 23.51B | |
| -3.19% | -7.16% | -6.48% | -26.86% | -42.71% | -5.20% | +351.40% | +305.35% | +758.13% | 22.35B | |
| -4.01% | -2.68% | +7.14% | +11.37% | +20.23% | +12.50% | -12.70% | -69.66% | - | 20.6B | |
| -1.23% | -3.15% | +2.73% | +9.11% | -9.03% | +26.00% | -33.84% | -34.96% | +51.40% | 17.45B | |
| -3.34% | -6.96% | +10.42% | +4.61% | +22.64% | +22.02% | +515.48% | - | - | 15.16B | |
| -0.17% | -1.09% | +1.17% | +23.81% | +25.59% | +49.36% | +179.27% | +226.68% | +493.80% | 13.91B | |
| -5.09% | -13.14% | -10.47% | +75.74% | +141.92% | +151.85% | +272.20% | +1,322.52% | +585.75% | 13.74B | |
| -12.02% | -11.44% | -10.38% | -6.99% | -17.37% | +66.00% | +134.39% | +451.09% | +6,884.18% | 12.61B | |
| -0.01% | -1.83% | +4.51% | +15.94% | +28.32% | +442.44% | +146.78% | +22.95% | +1,353.75% | 12.14B | |
| -2.56% | -5.76% | +1.69% | -31.57% | -17.52% | -40.10% | +117.00% | +82.75% | - | 11.23B | |
| +2.40% | -2.42% | -6.16% | +24.96% | +25.81% | +120.95% | +139.70% | +169.34% | +595.74% | 10.64B | |
| +2.93% | -12.88% | -10.43% | -39.19% | -25.39% | -51.05% | +521.43% | +78.04% | +96.24% | 10.21B | |
| +0.02% | 0.00% | +0.36% | +25.09% | +23.23% | +56.50% | +155.59% | +561.12% | - | 9.83B | |
| -0.08% | +0.16% | +123.90% | +116.05% | +79.99% | +186.64% | +340.97% | +365.99% | - | 8.84B | |
| +1.47% | -1.29% | +11.18% | +32.58% | +201.30% | +470.88% | +598.67% | -35.59% | -17.23% | 8.61B | |
| -4.05% | -7.46% | -0.38% | -20.68% | +10.28% | +13.43% | +67.51% | -21.70% | - | 8.37B | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +47.55% | +79.55% | - | 8.19B | |
| Average | -1.52% | -1.82% | +5.80% | +13.74% | +25.76% | +88.58% | +180.58% | +184.34% | +1,516.52% | 16.96B | |
| Weighted average by Cap. | -2.09% | -1.14% | +1.65% | +9.99% | +20.50% | +59.78% | +150.05% | +160.89% | +2,660.20% |
- Stock Market
- Stocks
- AVTX Stock
- Sector Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
